Healthcare Sales & Marketing Network News: DIASTAT

Searching News Database: DIASTAT

HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Dec 2012
Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Oct 2007
Barr and Par Settle Diazepam Rectal Gel Patent Challenge with Valeant
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Jul 2007
Valeant Pharmaceuticals Settles Suit with Kali Laboratories on Diastat Generic Challenge
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 25 Jan 2007
Valeant Pharmaceuticals Developing Intranasal Diazepam for the At-Home Treatment of Emergency Seizures
Biopharmaceuticals Drug Delivery Neurology

Return to NewsFeed

Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 5 additional stories matching:
DIASTAT
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.